80 related articles for article (PubMed ID: 15055987)
1. 3,3-diaryl-1,3-dihydroindol-2-ones as antiproliferatives mediated by translation initiation inhibition.
Natarajan A; Fan YH; Chen H; Guo Y; Iyasere J; Harbinski F; Christ WJ; Aktas H; Halperin JA
J Med Chem; 2004 Apr; 47(8):1882-5. PubMed ID: 15055987
[TBL] [Abstract][Full Text] [Related]
2. Structure-activity requirements for the antiproliferative effect of troglitazone derivatives mediated by depletion of intracellular calcium.
Fan YH; Chen H; Natarajan A; Guo Y; Harbinski F; Iyasere J; Christ W; Aktas H; Halperin JA
Bioorg Med Chem Lett; 2004 May; 14(10):2547-50. PubMed ID: 15109648
[TBL] [Abstract][Full Text] [Related]
3. Novel arylsulfoanilide-oxindole hybrid as an anticancer agent that inhibits translation initiation.
Natarajan A; Guo Y; Harbinski F; Fan YH; Chen H; Luus L; Diercks J; Aktas H; Chorev M; Halperin JA
J Med Chem; 2004 Oct; 47(21):4979-82. PubMed ID: 15456240
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and biological evaluation of thiazolidine-2,4-dione and 2,4-thione derivatives as inhibitors of translation initiation.
Chen H; Fan YH; Natarajan A; Guo Y; Iyasere J; Harbinski F; Luus L; Christ W; Aktas H; Halperin JA
Bioorg Med Chem Lett; 2004 Nov; 14(21):5401-5. PubMed ID: 15454234
[TBL] [Abstract][Full Text] [Related]
5. Depletion of intracellular Ca2+ stores, phosphorylation of eIF2alpha, and sustained inhibition of translation initiation mediate the anticancer effects of clotrimazole.
Aktas H; Flückiger R; Acosta JA; Savage JM; Palakurthi SS; Halperin JA
Proc Natl Acad Sci U S A; 1998 Jul; 95(14):8280-5. PubMed ID: 9653178
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and SAR study of novel 3,3-diphenyl-1,3-dihydroindol-2-one derivatives as potent eIF2·GTP·Met-tRNAiMet ternary complex inhibitors.
Denoyelle S; Chen T; Yang H; Chen L; Zhang Y; Halperin JA; Aktas BH; Chorev M
Eur J Med Chem; 2013 Nov; 69():537-53. PubMed ID: 24095748
[TBL] [Abstract][Full Text] [Related]
7. Role of symmetry in 3,3-diphenyl-1,3-dihydroindol-2-one derivatives as inhibitors of translation initiation.
Yang H; Chen T; Denoyelle S; Chen L; Fan J; Zhang Y; Halperin JA; Chorev M; Aktas BH
Bioorg Med Chem Lett; 2023 Jan; 80():129119. PubMed ID: 36581302
[TBL] [Abstract][Full Text] [Related]
8. Substituted E-3-(3-indolylmethylene)1,3-dihydroindol-2-ones with antiproliferative activity. Study of the effects on HL-60 leukemia cells.
Leoni A; Locatelli A; Morigi R; Rambaldi M; Cappadone C; Farruggia G; Iotti S; Merolle L; Zini M; Stefanelli C
Eur J Med Chem; 2014 May; 79():382-90. PubMed ID: 24747749
[TBL] [Abstract][Full Text] [Related]
9. Antitumor activity of substituted E-3-(3,4,5-trimethoxybenzylidene)-1,3-dihydroindol-2-ones1.
Andreani A; Burnelli S; Granaiola M; Leoni A; Locatelli A; Morigi R; Rambaldi M; Varoli L; Kunkel MW
J Med Chem; 2006 Nov; 49(23):6922-4. PubMed ID: 17154522
[TBL] [Abstract][Full Text] [Related]
10. Glucose activates a protein phosphatase-1-mediated signaling pathway to enhance overall translation in pancreatic beta-cells.
Vander Mierde D; Scheuner D; Quintens R; Patel R; Song B; Tsukamoto K; Beullens M; Kaufman RJ; Bollen M; Schuit FC
Endocrinology; 2007 Feb; 148(2):609-17. PubMed ID: 17082262
[TBL] [Abstract][Full Text] [Related]
11. Regulation of protein synthesis in ventricular myocytes by vasopressin. The role of sarcoplasmic/endoplasmic reticulum Ca2+ stores.
Reilly BA; Brostrom MA; Brostrom CO
J Biol Chem; 1998 Feb; 273(6):3747-55. PubMed ID: 9452507
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and antitumor activity of 1,5,6-substituted E-3-(2-chloro-3-indolylmethylene)-1,3-dihydroindol-2-ones.
Andreani A; Granaiola M; Leoni A; Locatelli A; Morigi R; Rambaldi M; Garaliene V
J Med Chem; 2002 Jun; 45(12):2666-9. PubMed ID: 12036377
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and biological evaluation of 2-indolinone derivatives as potential antitumor agents.
Zou H; Zhang L; Ouyang J; Giulianotti MA; Yu Y
Eur J Med Chem; 2011 Dec; 46(12):5970-7. PubMed ID: 22019188
[TBL] [Abstract][Full Text] [Related]
14. Quinols as novel therapeutic agents. 2.(1) 4-(1-Arylsulfonylindol-2-yl)-4-hydroxycyclohexa-2,5-dien-1-ones and related agents as potent and selective antitumor agents.
Berry JM; Bradshaw TD; Fichtner I; Ren R; Schwalbe CH; Wells G; Chew EH; Stevens MF; Westwell AD
J Med Chem; 2005 Jan; 48(2):639-44. PubMed ID: 15658878
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and evaluation of novel 7-azaindazolyl-indolyl-maleimide derivatives as antitumor agents and protein kinase C inhibitors.
Ye Q; Cao J; Zhou X; Lv D; He Q; Yang B; Hu Y
Bioorg Med Chem; 2009 Jul; 17(13):4763-72. PubMed ID: 19447039
[TBL] [Abstract][Full Text] [Related]
16. Design, synthesis, and evaluation of 3,4-dihydro-2H-[1,4]diazepino[6,7,1-hi]indol-1-ones as inhibitors of poly(ADP-ribose) polymerase.
Tikhe JG; Webber SE; Hostomsky Z; Maegley KA; Ekkers A; Li J; Yu XH; Almassy RJ; Kumpf RA; Boritzki TJ; Zhang C; Calabrese CR; Curtin NJ; Kyle S; Thomas HD; Wang LZ; Calvert AH; Golding BT; Griffin RJ; Newell DR
J Med Chem; 2004 Oct; 47(22):5467-81. PubMed ID: 15481984
[TBL] [Abstract][Full Text] [Related]
17. Substituted E-3-(2-Chloro-3-indolylmethylene)1,3-dihydroindol-2-ones with antitumor activity.
Andreani A; Granaiola M; Leoni A; Locatelli A; Morigi R; Rambaldi M; Garaliene V; Farruggia G; Masotti L
Bioorg Med Chem; 2004 Mar; 12(5):1121-8. PubMed ID: 14980624
[TBL] [Abstract][Full Text] [Related]
18. Novel inhibitors of epidermal growth factor receptor: (4-(Arylamino)-7H-pyrrolo[2,3-d]pyrimidin-6-yl)(1H-indol-2-yl)methanones and (1H-indol-2-yl)(4-(phenylamino)thieno[2,3-d]pyrimidin-6-yl)methanones.
Beckers T; Sellmer A; Eichhorn E; Pongratz H; Schächtele C; Totzke F; Kelter G; Krumbach R; Fiebig HH; Böhmer FD; Mahboobi S
Bioorg Med Chem; 2012 Jan; 20(1):125-36. PubMed ID: 22169601
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of insulin synthesis by cyproheptadine: effects on translation.
Hawkins BS; Fischer LJ
Toxicol Sci; 2004 Jun; 79(2):258-65. PubMed ID: 15056814
[TBL] [Abstract][Full Text] [Related]
20. Synthesis of 1-(2,6-dichlorophenyl)-3-methylene-1,3-dihydro-indol-2-one derivatives and in vitro anticancer evaluation against SW620 colon cancer cell line.
Virsodia V; Manvar A; Upadhyay K; Loriya R; Karia D; Jaggi M; Singh A; Mukherjee R; Shaikh MS; Coutinho EC; Shah A
Eur J Med Chem; 2009 Mar; 44(3):1355-62. PubMed ID: 18316139
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
